# Caisson Transcatheter Mitral Valve Replacement (TMVR) System Early Feasibility Study

> **NCT02768402** · NA · UNKNOWN · sponsor: **Caisson Interventional LLC** · enrollment: 20 (estimated)

## Conditions studied

- Mitral Valve Regurgitation

## Interventions

- **DEVICE:** Caisson TMVR System

## Key facts

- **NCT ID:** NCT02768402
- **Lead sponsor:** Caisson Interventional LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2023-09
- **Final completion:** 2023-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02768402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02768402, "Caisson Transcatheter Mitral Valve Replacement (TMVR) System Early Feasibility Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02768402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
